Vofopitant (GR205171) is a drug which acts as an NK1 receptor antagonist.

It has antiemetic effects as with other NK1 antagonists,[1] and also shows anxiolytic actions in animals.

[2] It was studied for applications such as the treatment of social phobia and post-traumatic stress disorder, but did not prove sufficiently effective to be marketed.

[3][4] This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.